RenovoRx RNXT
NASDAQ RNXT
$1.25 +0.05 (+4.57%)
As of: Oct 21, 2026 · 1:54 PM EDT

RenovoRx (RNXT) Total Non-Current Liabilities (2020)

Updated

RenovoRx's Total Non-Current Liabilities was $15.71 million in Q4 2020.

Analysis

RenovoRx (RNXT) Total Non-Current Liabilities (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Thermo Fisher Scientific 257.40 Bn 236.43 Bn 4.88 Bn 55.95 Bn
2 Abbott Laboratories 171.36 Bn 141.79 Bn 7.27 Bn -
3 Danaher 162.74 Bn 146.55 Bn 3.61 Bn 33.25 Bn
4 Intuitive Surgical 151.33 Bn 130.75 Bn 1.96 Bn -
5 Medtronic 119.71 Bn 84.96 Bn 6.34 Bn 38.93 Bn
6 Stryker 113.86 Bn 99.98 Bn 4.50 Bn 20.88 Bn
7 Boston Scientific 65.28 Bn 60.05 Bn 3.85 Bn 17.56 Bn
8 Becton Dickinson 53.52 Bn 50.67 Bn 2.32 Bn 23.92 Bn
9 Edwards Lifesciences 50.89 Bn 34.90 Bn 1.35 Bn 2.19 Bn
10 RenovoRx 59.36 Mn 20.39 Mn 766,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 15.71 Mn
API Access

RenovoRx Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=RNXT&period=max&api_key=YOUR_API_KEY